Projects

There are currently three major projects that we are focusing for developments:

  1. QMS-1001 contains small molecule compounds designed for the therapy of multiple sclerosis by synergistic target effects.

  2. QMS-2001 contains small molecule compounds designed for the therapy of cancers through the function of immune modulations.

  3. QMS-ND-001 is a project of new route of administration for drug delivery, which is facilitated by a new type of device.